Clinical Trials Logo

Filter by:
NCT ID: NCT04996719 Completed - Heart Failure Clinical Trials

Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults

Start date: May 24, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this research is to see if the drug rapamycin will improve the heart's ability to pump by improving your oxygen consumption.

NCT ID: NCT04996563 Completed - Clinical trials for Pelvic Organ Prolapse

Patient Educational Video for Pelvic Organ Prolapse

Start date: August 2, 2021
Phase: N/A
Study type: Interventional

This is a single-blinded, randomized controlled trial investigating if a patient educational video on pelvic organ prolapse improves patient understanding of this pelvic floor disorder and satisfaction in their healthcare decision making for its management.

NCT ID: NCT04996264 Completed - Envenoming, Snake Clinical Trials

Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite

BRAVO
Start date: August 15, 2021
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, phase 2 study designed to evaluate the safety, tolerability and efficacy of varespladib-methyl, concurrently with standard of care (SOC), in subjects bitten by venomous snakes.

NCT ID: NCT04996251 Completed - Pain, Postoperative Clinical Trials

Pre-incision Versus Post-incision Local Anesthetic During Robotic Sacrocolpopexy

CLAPPS
Start date: July 30, 2021
Phase: Phase 4
Study type: Interventional

Obtaining Likest-pain scale score on postoperative day one after injection of local anesthetic into incision sites of a laparoscopic/robotic-assisted sacrocolpopexy

NCT ID: NCT04996069 Completed - Xerostomia Clinical Trials

Exploratory Study on Effect of Whitening Agent With Emulsion Gel in Xerostomic Population

Start date: August 9, 2021
Phase: N/A
Study type: Interventional

Xerostomia, is a subjective sensation of dryness of the mouth. There are more than 700 medications that can lead to the salivary hypofunction that results in dry mouth. This study will investigate a semi solid cohesive gel (referred to as Whitening Gel) that has the primary marketed purpose of teeth whitening. We theorize that the whitening gel's retention in the oral cavity is longer than rinse forms and this is likely to promote the flow of saliva by stimulating taste buds which could alleviate the sensation of dryness in the oral cavity. This will be a single center, two visit study investigating the effectiveness of dryness in the oral cavity, whiteness of teeth, and teeth sensitivity after one week's use of whitening agent.

NCT ID: NCT04995887 Completed - Clinical trials for Postpartum Hemorrhage

RUBY Post-Market Registry on the Jada® System

RUBY
Start date: October 1, 2020
Phase:
Study type: Observational

The RUBY Study is a multicenter, observational, post-market registry designed to collect observational data on patients treated with the Jada System in the post-market setting.

NCT ID: NCT04995796 Completed - Tetraplegia Clinical Trials

Testing the Decision Aid: Supporting Patient Decisions About Upper Extremity Surgery in Cervical SCI

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

Purpose: The objective of this study is to assess a newly created decision support intervention (DSI) or decision aid (DA) for people with spinal cord injury (SCI) to learn about and consider upper extremity reconstructive surgery to help them choose a course of treatment that most aligns with their values.

NCT ID: NCT04995770 Completed - Clinical trials for Medication Adherence

Text Messages for Liver Transplant Recipients

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

Although medical advancements have enabled children experiencing liver transplants to live longer, medical management post-transplant is ongoing and complex. Many findings underscore adolescents as being a particularly vulnerable population, with rates of nonadherence being four times higher than in adults. This pilot study aims to explore the feasibility and impact of a brief text-messaging intervention in a randomized controlled trials (N = 50). We have three primary aims: 1) Study patient satisfaction with and utilization of this intervention in order to better understand feasibility and acceptability; 2) Investigate the effects of this intervention on medication adherence, healthcare utilization, and health status; and 3) Examine potential effects of the intervention on the physician-patient relationship, motivation for adherence, and other variables.

NCT ID: NCT04995692 Completed - Asthma in Children Clinical Trials

Telehealth Education for Asthma Connecting Hospital and Home

TEACHH
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The goal of this study is to evaluate the feasibility, acceptability, and preliminary efficacy of a technology-enhanced educational intervention for caregivers and children who are hospitalized due to asthma. We will conduct a pilot RCT with 60 children (5-13 yrs) hospitalized with asthma at the Golisano Children's Hospital in Rochester, NY. After baseline assessment, subjects will be randomized to either: 1) the Telehealth Education for Asthma Connecting Hospital and Home (TEACHH) intervention, which includes inpatient child/caregiver education using pictorial materials, color/shape labels for home medications (green star=controller, yellow/red circles=rescue), and a pair of in-home, smartphone-based telehealth visits after discharge to reinforce effective home management; or, 2) the standard care (SC) condition, which features standard inpatient education and routine outpatient follow-up. Patients in TEACHH will also receive all SC measures. All caregivers will complete blinded telephone follow-up assessments at 2, 4, and 6 months after discharge; children will be asked medication questions at baseline and 6 months. We will describe the feasibility and acceptability of implementing the TEACHH intervention by reviewing process measure data collected throughout the study; assess the preliminary efficacy of TEACHH in improving key clinical outcomes, including asthma-related ACU at 7 days, 30 days, and 6 months (per electronic health record documentation) and symptom-free days at each follow-up (reported by caregivers); and assess secondary clinical and functional outcomes including asthma-related quality of life, missed school or work due to asthma, caregiver and child medication knowledge, and reported adherence. We will also invite all caregivers to complete a semi-structured qualitative interview (1 month after baseline for the TEACHH group, 6 months after baseline for the SC group). Findings from this work will establish a strong foundation for a full-scale trial, and guide future efforts to deliver guideline-based asthma care to underserved children and families at the greatest risk for preventable morbidity.

NCT ID: NCT04995666 Completed - Hearing Loss Clinical Trials

Hearing Aid Quality and Reliability Study

Start date: June 8, 2021
Phase: N/A
Study type: Interventional

Quality and reliability study of hearing aid. Adults with mild to severe hearing loss will wear hearing aids daily for approximately 3 months.